Back
Marinus Pharmaceuticals Stock Price Chart
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Sell
34
MRNS
Marinus Pharmaceuticals
Last Price:
1.49
Seasonality Move:
-0.7%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing selling pressure, which indicates risk of future bearish movement.
Marinus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.44 | Buy |
| 20-day SMA: | 3.06 | Sell |
| 50-day SMA: | 6.7 | Sell |
| 200-day SMA: | 7.86 | Sell |
| 8-day EMA: | 1.6 | Sell |
| 20-day EMA: | 3.01 | Sell |
| 50-day EMA: | 5.56 | Sell |
| 200-day EMA: | 7.56 | Sell |
Marinus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.71 | Sell |
| Relative Strength Index (14 RSI): | 17.14 | Sell |
| Chaikin Money Flow: | -1037081 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.78 - 7.56) | Sell |
| Bollinger Bands (100): | (5.33 - 11.31) | Sell |
Marinus Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marinus Pharmaceuticals Stock
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 1.51 while MRNS 8-day simple moving average is 1.44, which is a Buy signal.
- The stock price of MRNS is 1.51 while Marinus Pharmaceuticals 20-day SMA is 3.06, which makes it a Sell.
- Marinus Pharmaceuticals 50-day simple moving average is 6.70 while MRNS share price is 1.51, making it a Sell technically.
- MRNS stock price is 1.51 and Marinus Pharmaceuticals 200-day simple moving average is 7.86, creating a Sell signal.
MRNS Technical Analysis vs Fundamental Analysis
Sell
34
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a Sell
The current Marinus Pharmaceuticals [MRNS] share price is $1.51. The Score for MRNS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Marinus Pharmaceuticals Stock Info
Market Cap:
82.95M
Price in USD:
1.51
Share Volume:
1.6M
Marinus Pharmaceuticals 52-Week Range
52-Week High:
11.26
52-Week Low:
1.11
Sell
34
Marinus Pharmaceuticals (MRNS)
is a Sell
Marinus Pharmaceuticals Share Price Forecast
-
What is the Marinus Pharmaceuticals stock price today?
The Marinus Pharmaceuticals stock price is 1.51 USD today. -
Will MRNS stock go up or go down?
Marinus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Marinus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marinus Pharmaceuticals is overvalued.
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 1.51 while MRNS 8-day exponential moving average is 1.60, which is a Sell signal.
- The stock price of MRNS is 1.51 while Marinus Pharmaceuticals 20-day EMA is 3.01, which makes it a Sell.
- Marinus Pharmaceuticals 50-day exponential moving average is 5.56 while MRNS share price is 1.51, making it a Sell technically.
- MRNS stock price is 1.51 and Marinus Pharmaceuticals 200-day simple moving average is 7.56, creating a Sell signal.
Fundamental Analysis of Marinus Pharmaceuticals
Is Marinus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.16 per share, an increase this year of $0.21 per share, and an increase next year of $0.89 per share.
Technical Analysis of Marinus Pharmaceuticals
Should I short Marinus Pharmaceuticals stock?
- MRNS Moving Average Covergence Divergence (MACD) indicator is -1.71, suggesting Marinus Pharmaceuticals is a Sell
- Marinus Pharmaceuticals Relative Strength Index (RSI) is 17.14, which suggest Marinus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Marinus Pharmaceuticals is (0.78 - 7.56), which suggest Marinus Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Marinus Pharmaceuticals is (5.33 - 11.31), which suggest Marinus Pharmaceuticals is a Sell
* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.